-
ASAM Calls for Medicaid Policies that Recognize Recovery Is Work
Full story -
The ASAM Weekly for July 21, 2026
Alcohol is our lead this week, anchored by a compelling new study tracking "Trends in Alcohol-Related Deaths in the United States Over 55 Years." While recent 2020s data offered some encouraging signals regarding use and impact, this long-term analysis reveals that alcohol-related mortality has increased substantially over more than five decades, with specific demographics bearing a disproportionate burden.Full story -
ASAM Joins Coalition Urging CMS to Rescind Proposal to Cap Medicaid Payments
On May 20, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would set caps on Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Practitioner Payments.Full story -
The ASAM Weekly for July 14, 2026
Initiating buprenorphine for opioid use disorder (OUD) in outpatient settings is more difficult for patients using fentanyl. There are research and published literature supporting this trend.Full story -
Guest Editorial: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting: Current State, Lessons Learned, and Future Direction
Explore how long-acting injectable buprenorphine (LAIB) provides a barrier-free way to initiate OUD treatment for patients using fentanyl.Full story -
ASAM Comment on OMB Proposal to Revise Federal Grant Rules
On July 13, the American Society of Addiction Medicine (ASAM) submitted a public comment to the White House Office of Management and Budget (OMB) in response to its proposed rule that would significantly alter Uniform Guidance governing federal grants, many of which are used to fund scientific research.Full story -
ASAM Recaps 2026 State Legislative Sessions with Mid-Year Report
The ASAM 2026 Mid-Year Report: Trends in Addiction Medicine State Legislation recaps major trends in addiction-related state policy.Full story -
ASAM Responds to HHS Request for Comment on the Chronic Disease of Addiction
On July 3, the American Society of Addiction Medicine (ASAM) submitted a letter to the Department of Health and Human Services (HHS) in response to its request for information (RFI) on the chronic disease of addiction.Full story -
The ASAM Weekly for July 7, 2026
From the rescheduling of cannabis and the surging prevalence of nicotine pouches like Zyn, to the structural setbacks face-to-face with the alcohol industry, our field is moving at a breakneck pace.Full story -
ASAM Welcomes Reintroduction of Bipartisan Legislation to Expand Medicare Coverage for Residential Addiction Treatment
Full story -
MASAM Supports Strong Health and Safety Regulation of Kratom Products
Full story -
The ASAM Weekly for June 30, 2026
One last commentary as EIC.Full story -
ASAM Applauds Bipartisan Legislation to Expand Access to Methadone Treatment for Opioid Use Disorder
Full story -
The ASAM Weekly for June 23, 2026
Social Media Use Trajectories and Substance Use ExperimentationFull story -
Guest Editorial – Stigma, Pity, and the Limits of Empathy
Explore the limits of empathy in healthcare. Learn how peer mentor O’Nesha Cochran’s lived experience challenges stigma and helps providers honor patient dignity.Full story -
The ASAM Weekly for June 16, 2026
Inclusion criteriaFull story -
MISAM Comments on Legislation Allowing Opioid Settlement Dollars to Fund Ibogaine Research
Full story -
The ASAM Weekly for June 9, 2026
EndtroducingFull story -
Dr. Smita Das Appointed Editor in Chief of The ASAM Weekly Newsletter
Full story -
FAQ: Medicaid Community Engagement Requirements — What New Rules Mean for Patients with a Substance Use Disorder
Full story